Tezepelumab demonstrated superiority versus placebo across every primary and keysecondary endpoint in NAVIGATOR Phase III trial Positive full results from…
Two South Africa sites added to TOGETHER platform trials for the outpatient treatment of high-risk adults infected with SARS-CoV-2 Cytel…
Combining APDM’s precision motion wearables and digital biomarkers with ERT’s eClinical Suite revolutionizes clinical trials ERT, the global leader in…
A new NHS report has detailed how more than 56% of adults are at increased, high or very high risk…
Currently, five PD-1/L1 inhibitors boast FDA approvals to treat certain bladder cancer patients. But only one of them is about…
MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice Capo…
Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy Thrombolytic Science, LLC (TSI) today announced progress with 10…
A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version…
Announces strategic partnership with alytas therapeutics Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional…
by Anna Smith Cambridge University Hospital NHS Foundation Trust has announced that its inflammatory bowel disease (IBD) research has hit…
